We are monitoring the impact of COVID-19 on North America Genetic Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 21
Share on
Share on

North America Genetic Testing Market Research Report - Segmented By Type, Application and Country (the United States, Canada and Rest of North America) - Size, Share, Growth, Trends, And Forecast (2021 to 2026)

Pulished: April, 2021
ID: 21
Pages: 138

North America Genetic Testing Market Size (2021 to 2026)

The size of the Genetic Testing Market in North America was valued at USD 19.23 billion in 2021. It is forecasted to be a USD 33.16 billion by 2026, growing at a CAGR of 11.52% during the forecast period. Genetic testing in cancer is expected to dominate the market and is likely to witness high growth shortly. The demand for rare and fatal disorders diagnosing, screening newborns, and the probability estimation of disease occurrence is expected to expand. Mainly, tests for screening the new-borns are expected to grow enormously over the coming years.

Currently, among the different segments of the molecular diagnostics market, genetic testing is most likely to be a highly attractive segment owing to the increasing need for superior healthcare. Genetic testing is a highly sophisticated form of testing where even a slight modification in DNA associated with any disease condition can be detected.

Genetic testing is the study of genes, chromosomes, or proteins that help identify the diseases, carriers of a disease, diagnose conditions, or determine its course. The evolution of genetic testing has enabled for easy diagnosis of diseases like sickle cell anemia, hemophilia, and cystic fibrosis, thus helping many patients to lead a healthy life.

An increase in awareness among individuals about the benefits and the potentiality of genetic testing to identify and cure diseases or abnormalities is the main reason for the genetic testing market to grow. Besides, an increase in the aging population, advancements of technology in the genetic testing space, subsequent increase in the cases of chronic diseases, and rising cancer case incidences are the few other factors aiding the growth of the genetic testing market in North America. With the growing genetic disease incidences, it unravels new opportunities for genetic testing and its related applications. The genetic testing transformation from being a service-driven market to a product-driven market is anticipated to push the diagnostic companies to expand their operations.

However, factors like huge costs associated with genetic testing and the lack of standard procedures concerning the authenticity of genetic reports hinder the growth of the North American genetic testing market.

This research report on the North American Genetic Testing Market has been segmented and sub-segmented into the following categories.

By Application: 

  • Cancer Testing
  • Pharmacogenomics testing
  • Prenatal testing 
  • Predisposition testing

By Test: 

  • Carrier Testing
  • Diagnostic Testing
  • Prenatal Testing
  • Neonatal Testing

By Country: 

  • The United States
  • Canada
  • Rest of North America

Regionally, the genetic testing market in the North American region is expected to lead globally throughout the forecast period. This domination is driven by the increasing occurrence rate of genetic diseases, growing awareness among the independents regarding the advantages and the capability of gene testing to cure the diseases and abnormalities that drive growth in this region.

In North America, the United States genetic testing market is accounted for in thriving the most significant shares of the market. Fatal disorder diagnosing, examining newborn babies, and enlargement of disease occurrence rate, increasing aging population, advanced technologies towards the genetic testing space, and growing cancer cases boost the growth in this region. One of the 15,000 children suffers from phenylketonuria every year. Regionally, the US represents the largest market for genetic testing worldwide. Screening for genetic mutations within the CFTR (Cystic Fibrosis Trans-Membrane Conductance Regulator) gene is the most recurrently conducted test in the US.

The Canadian genetic testing market growth is expected to have fast growth over the review period due to reimbursement policies, spreading awareness relevant to genetic testing. According to the Canadian Cancer Society, approximately 220,400 cancer cases are reported in Canada. Moreover, growing healthcare expenditure and the genetic testing that assists the patients in proper treatment may accelerate the growth.

Notable companies operating in the North American Genetic Testing Market profiled in this report are Abbott Laboratories, Roche Molecular Diagnostics Inc., Abbott Molecular Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Roche Diagnostics Corp., Quest Diagnostics Inc., Transgenomic Inc., and Applied Biosystems Inc.


                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Type        

                                5.1.1 Carrier Testing

                                5.1.2 Diagnostic Testing

                                5.1.3 Prenatal Testing

                                5.1.4 Neonatal Testing

                5.2 By Application           

                                5.2.1 Cancer Testing

                                5.2.2 Prenatal Testing

                                5.2.3 Pharmacogenomics Testing

                                5.2.4 Presdisposition Testing

6. Geographical Analysis                              

                6.1 Introduction              

                6.2 United States            

                6.3 Canada         

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Roche Molecular Diagnostics Inc.      

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Abbott Laboratories

                8.3 AutoGenomics Inc. 

                8.4 Celera Group             

                8.5 ELITech Group          

                8.6 BioRad Laboratories

                8.7 Quest Diagnostics Inc             

                8.8 Transgenomic Inc.   

                8.9 Applied Biosystems Inc.,       

                8.10 PerkinElmer Inc      

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 


                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Genetic Testing Market By Region, From 2021 to 2026 (USD Billion)
  2. North America Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  3. North America Carrier Testing Market By Region, From 2021 to 2026 (USD Billion)
  4. North America Diagnostic Testing Market By Region, From 2021 to 2026 (USD Billion)
  5. North America Prenatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  6. North America Neonatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  7. North America Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)
  8. North America Cancer Testing Market By Region, From 2021 to 2026 (USD Billion)
  9. North America Prenatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  10. North America Pharmacogenomics Testing Market By Region, From 2021 to 2026 (USD Billion)
  11. North America Predisposition Testing Market By Region, From 2021 to 2026 (USD Billion)
  12. United States Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  13. United States Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)
  14. Canada Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  15. Canada Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample